US Patent Issued to MedImmune, Humabs BioMed on May 27 for "Anti-O2 antibodies and uses thereof" (Swiss, American Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,397, issued on May 27, was assigned to MedImmune LLC (Gaithersburg, Md.) and Humabs BioMed SA (Bellinzona, Switzerland).

"Anti-O2 antibodies and uses thereof" was invented by Qun Wang (Gaithersburg, Md.), Meghan Pennini (Gaithersburg, Md.), Xiaodong Xiao (Gaithersburg, Md.), Davide Corti (Bellinzona, Switzerland), Elisabetta Cameroni (Bellinzona, Switzerland), Martina Beltramello (Bellinzona, Switzerland), Gilad Kaplan (Gaithersburg, Md.), Anna DeMarco (Bellinzona, Switzerland) and Charles K. Stover (Gaithersburg, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides binding proteins (e.g., antibodies or antigen binding ...